Zobrazeno 1 - 10
of 98
pro vyhledávání: '"S. S. Sachdev"'
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 165:261-267
No-carrier-added (nca)-131I-meta-Iodobenzylguadine (mIBG) is a clinical agent used for the therapy of Neuroendocrine tumors. It is prepared by reaction of radioiodine with precursors that are chemically different from mIBG. The precursor in few cases
Autor:
Haladhar Dev Sarma, M. Sheela, Soumen Das, Madhava B. Mallia, Anupam Mathur, Shubhangi Mirapurkar, Ashutosh Dash, S. S. Sachdev, Navin Sakhare
Publikováno v:
Nuclear Medicine and Biology. :49-57
Introduction meta-[123/131I]Iodobenzylguanidine (mIBG) is a clinical agent used for imaging neuroendocrine tumors, where uptake in tumor is via active transport mechanism through norepinephrine transporters (NET). Our group in past have evaluated a 9
Publikováno v:
Indian Journal of Public Health Research & Development.
Background: Air-borne droplets constitute the main route of transmission of COVID-19. Considering theexponential increase in number of cases, it has become the need of the hour to develop additional measuresto limit the spread of infection.Materials
Autor:
Madhava B. Mallia, Haladhar Dev Sarma, Soumen Das, Ashutosh Dash, Anupam Mathur, S. S. Sachdev, Navin Sakhare
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 61:1048-1057
123 I-Iodophenylpentadecanoic acid (IPPA) is a metabolic agent used in nuclear medicine for diagnosis of myocardial defects. Efforts are underway worldwide to develop a 99m Tc substitute of the above radiopharmaceutical for the aforementioned applica
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 318:1287-1295
99mTc-ethylene dicysteine diethyl ester (99mTc-ECD) is an established radiopharmaceutical used for brain perfusion imaging; however it does not have any recognized biological quality control to ascertain its in vivo efficacy. The present paper descri
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Repaka Krishna Mohan, Ravi Seshan, Sandip Basu, S. S. Sachdev, Anupam Mathur, Vrinda Prashant, K.V. Vimalnath, Barkha Karkhanis, Navin Sakhare, Aruna Korde, Sharmila Banerjee, Chanda Arjun, Sudipta Chakraborty, Ashutosh Dash
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 32:266-273
Introduction: 177Lu-DOTA-TATE is a clinically useful and promising therapeutic radiopharmaceutical for peptide receptor radionuclide therapy of neuroendocrine tumors (NETs) overexpressing ...
Autor:
Suraj Muke, S. S. Sachdev, Jayula Sarnaik, Aakruti Kaikini, Divya Dhodi, Vijay Kadwad, Sadhana Sathaye, Aruna Korde, Vaibhavi Peshattiwar, Sneha Bagle
Publikováno v:
Journal of Pharmacy & Bioallied Sciences
Journal of Pharmacy and Bioallied Sciences, Vol 12, Iss 3, Pp 295-307 (2020)
Journal of Pharmacy and Bioallied Sciences, Vol 12, Iss 3, Pp 295-307 (2020)
Background: Diabetes mellitus and its complications, such as nephropathy, represent a global burden. Recent research focuses on developing drugs that specifically target the pathogenesis of diabetic nephropathy rather than merely treating hyperglycem
Autor:
Shubhangi Mirapurkar, Soumen Das, Haladhar Dev Sarma, S. S. Sachdev, Anupam Mathur, Shalaka Paradkar, Navin Sakhare
Publikováno v:
RSC Advances. 6:64902-64910
Radio-iodine (123I/131I) labeled meta-iodobenzylguanidine (mIBG) is a proven radiopharmaceutical used for diagnosis of neuroendocrine tumors (NET) related to neural crest origin. Here, a 99mTc analogue of *I-mIBG using 99mTc-4+1 labeling approach has
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 165
No-carrier-added (nca)